ANALYTICAL METHODOLOGIES

Defined Methods. Structured Evaluation. Context-Appropriate Review.

Analytical Approach

Analytical evaluation within the PureLux Bio framework is structured around methodologies appropriate to compound structure, material characteristics, and Research Use Only (RUO) standards.

Methods are selected based on scientific suitability rather than promotional positioning. Analytical review is conducted on representative lot samples to support identity confirmation, purity assessment, and documentation continuity within the defined release framework.

Analytical methodologies are applied in alignment with internal evaluation standards and, where applicable, independent laboratory collaboration.

🧬 Identity Confirmation

Compound identity is evaluated using analytical techniques appropriate to molecular structure. Methods may include mass spectrometry or other structural confirmation techniques suitable for peptide and small molecule analysis.

Identity confirmation is intended to verify that the evaluated lot sample aligns with the expected molecular profile prior to release authorization.

📊 Chromatographic Purity Assessment

Purity evaluation is typically performed using high-performance liquid chromatography (HPLC) or comparable chromatographic methods.

Chromatographic analysis provides relative purity data based on peak integration and retention characteristics. Reported purity values reflect the evaluated lot sample and are documented accordingly.

Purity values do not imply pharmaceutical-grade designation, sterility certification beyond documented scope, or suitability for any non-research application.

🧪 Endotoxin Screening (Where Applicable)

For compounds where endotoxin presence may be relevant to laboratory handling conditions, screening may be performed using LAL-based methodologies or comparable techniques.

Endotoxin evaluation is applied selectively based on compound profile and intended laboratory context. It does not imply suitability for human or veterinary exposure.

Method Selection & Variability

Analytical scope may vary depending on compound complexity, production scale, structural modifications, and material profile.

Certain higher-volume SKUs may undergo more frequent analytical review, while lower-volume or specialty compounds may follow defined periodic evaluation schedules within the broader verification framework.

Method selection and frequency are determined according to internal standards designed to support documentation integrity and release discipline.

Documentation & Reporting

Analytical findings are documented and linked to corresponding lot identifiers. Where independent laboratory collaboration is utilized, reports may include third-party documentation generated by Freedom Diagnostics or other qualified laboratory partners.

Certificates of Analysis reflect the analytical scope applied to the evaluated lot sample and are provided to support transparency within the Research Use Only environment.

Analytical documentation is not a regulatory filing, clinical validation, or therapeutic certification.

Boundaries of Analytical Evaluation

Analytical methodologies applied within the PureLux Bio framework are designed to support research documentation, traceability, and release review.

They do not guarantee experimental outcomes, eliminate purchaser responsibility for independent evaluation, or authorize any use outside of lawful laboratory Research Use Only applications.

All materials remain designated strictly for Research Use Only.